Manufacture

What can be done to improve logistics? And which mode of transport should companies choose?

Patient adherence is a known issue, but what role does packaging play?

There is a lack of attention given to racemization in drug discovery…

FDA Commissioner Scott Gottlieb wants more biosimilars on the US market.

A new collaboration aims to put ancient Chinese ingredients to the test.

Different options can help to minimize the risk of delamination, protecting sensitive drugs or improving lyophilization results.

The increasing number of highly toxic and/or sensitive drugs is driving innovation in glass technology…

We believe a standardized approach to primary packaging will give companies more filling-line flexibility.

Are we entering a new era of continuous bioprocessing? Pall’s experts discuss the opportunities and challenges ahead.

Ten thousand reactions per hour – or else? No problem!